Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Esophagogastric Junction/drug effects"'
Autor:
Magdalena Jadwiga Utsch, Anna Krilova, Özlem Türeci, Martin Schuler, Karl Dhaene, Markus Jerling, Christoph Rohde, Stefan Bauer, Tobias Dechow, Ugur Sahin, Heike Richly, Christoph Huber
Introduction IMAB362 (Zolbetuximab) is a chimeric monoclonal antibody that binds to Claudin-18.2, a target antigen specific to cancer cells. In vitro, IMAB362 mediates cell death through antibody-dependent cellular cytotoxicity and complement-depende
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdb9949f013111d7e7dd98d889459c98
https://doi.org/10.1016/j.ejca.2018.05.007
https://doi.org/10.1016/j.ejca.2018.05.007
Autor:
J Mellor, Lars Bo Svendsen, M Illsley, Christophe Mariette, K Hofland, S. M. Griffin, G O’Dowd, Narayanasamy Ravi, George B. Hanna, R Mc Dermott, Claire L. Donohoe, Bryan T. Hennessy, Sinead Cuffe, Dermot O'Toole, Gregory D. Leonard, K Lee, K. Scott, G Jones, I Parker, Shaun R. Preston, Lene Baeksgaard, M Cunnane, Pablo M. Lawner, Tom Crosby, Seamus O'Reilly, V Marchesin, C Johnson, Cian Muldoon, AK Corkhill, S Warren, John V. Reynolds, Moya Cunningham, M Dib, B O’Neill
Publikováno v:
Reynolds, J V, Preston, S R, O'Neill, B, Baeksgaard, L, Griffin, S M, Mariette, C, Cuffe, S, Cunningham, M, Crosby, T, Parker, I, Hofland, K, Hanna, G, Svendsen, L B, Donohoe, C L, Muldoon, C, O'Toole, D, Johnson, C, Ravi, N, Jones, G, Corkhill, A K, Illsley, M, Mellor, J, Lee, K, Dib, M, Marchesin, V, Cunnane, M, Scott, K, Lawner, P, Warren, S, O'Reilly, S, O'Dowd, G, Leonard, G, Hennessy, B & Dermott, R M 2017, ' ICORG 10-14 : NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS) ', B M C Cancer, vol. 17, 401 . https://doi.org/10.1186/s12885-017-3386-2
BMC Cancer, Vol 17, Iss 1, Pp 1-10 (2017)
BMC Cancer
BMC Cancer, Vol 17, Iss 1, Pp 1-10 (2017)
BMC Cancer
Background Neoadjuvant therapy is increasingly the standard of care in the management of locally advanced adenocarcinoma of the oesophagus and junction (AEG). In randomised controlled trials (RCTs), the MAGIC regimen of pre- and postoperative chemoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b993161e8515b06273bfc9a1e222ce7
https://curis.ku.dk/portal/da/publications/icorg-1014(31db130e-532e-4195-a5bb-f2b3044ce10c).html
https://curis.ku.dk/portal/da/publications/icorg-1014(31db130e-532e-4195-a5bb-f2b3044ce10c).html
Publikováno v:
Expert review of gastroenterologyhepatology. 5(1)
Author for correspondence: Department of Surgery, Ioannina University School of Medicine, Ioannina, TK 451 10, Greece and Personalized Cancer Networks Medicine, Biobank, Ioannina University, Ioannina, TK 451 10, Greece Tel.: +30 265 100 7423 Fax: +30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::595d56be7c253c32777ace660735b8e1
https://pubmed.ncbi.nlm.nih.gov/21309665
https://pubmed.ncbi.nlm.nih.gov/21309665
